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Abstract
Background: The population of Japan has achieved the longest life expectancy in the world. To further improve population
health, consistent and comparative evidence on mortality attributable to preventable risk factors is necessary for setting
priorities for health policies and programs. Although several past studies have quantified the impact of individual risk
factors in Japan, to our knowledge no study has assessed and compared the effects of multiple modifiable risk factors for
non-communicable diseases and injuries using a standard framework. We estimated the effects of 16 risk factors on cause-
specific deaths and life expectancy in Japan.
Methods and Findings: We obtained data on risk factor exposures from the National Health and Nutrition Survey and
epidemiological studies, data on the number of cause-specific deaths from vital records adjusted for ill-defined codes, and
data on relative risks from epidemiological studies and meta-analyses. We applied a comparative risk assessment framework
to estimate effects of excess risks on deaths and life expectancy at age 40 y. In 2007, tobacco smoking and high blood
pressure accounted for 129,000 deaths (95% CI: 115,000–154,000) and 104,000 deaths (95% CI: 86,000–119,000),
respectively, followed by physical inactivity (52,000 deaths, 95% CI: 47,000–58,000), high blood glucose (34,000 deaths, 95%
CI: 26,000–43,000), high dietary salt intake (34,000 deaths, 95% CI: 27,000–39,000), and alcohol use (31,000 deaths, 95% CI:
28,000–35,000). In recent decades, cancer mortality attributable to tobacco smoking has increased in the elderly, while
stroke mortality attributable to high blood pressure has declined. Life expectancy at age 40 y in 2007 would have been
extended by 1.4 y for both sexes (men, 95% CI: 1.3–1.6; women, 95% CI: 1.2–1.7) if exposures to multiple cardiovascular risk
factors had been reduced to their optimal levels as determined by a theoretical-minimum-risk exposure distribution.
Conclusions: Tobacco smoking and high blood pressure are the two major risk factors for adult mortality from non-
communicable diseases and injuries in Japan. There is a large potential population health gain if multiple risk factors are
jointly controlled.
Please see later in the article for the Editors’ Summary.
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Controlling risk factors for non-communicable diseases and
external causes is essential for the improvement of adult health.
Chronic diseases and injuries are the leading causes of global
mortality, accounting for 63% and 9%, respectively, of 57 million
deaths in 2008 [1]. The five major risk factors for deaths in the
world are high blood pressure, tobacco use, high blood glucose,
physical inactivity, and overweight and obesity, which contribute
to non-communicable diseases and are modifiable with effective
interventions [2]. In such an environment, informed decision-
making on priority setting for health policies and programs needs
consistent and comparative evidence about how many deaths
would be averted by changing profiles of preventable risk factors in
a population.
The population of Japan has the longest life expectancy at birth
in the world. Life expectancy at birth for Japanese women was
54.0 y in 1947 and rapidly increased until 1986, at which point, at
81.0 y, it became the longest in the world for the first time; female
life expectancy at birth also reached its highest ever worldwide
figure, 86.4 y, in Japan in 2009 [3]. The continuous extension of
longevity was largely explained by a decline in the rate of mortality
for communicable diseases among children and young adults
during the 1950s and the early 1960s and for stroke since the late
1960s [4]. Current leading causes of death are malignant
neoplasm, heart disease, and cerebrovascular disease, accounting
for more than 50% of total deaths in 2009 [5]. Accidental injuries
and suicide have also ranked in the top ten causes of death for the
past 50 y [5], and particularly suicide in the working population is
a serious social problem reflecting the prolonged economic
recession since the 1990s [4]. To further enhance the health
status of the Japanese population, it is therefore crucial to prevent
deaths from these major causes.
With the aim of increasing the nation’s health through the
prevention of premature deaths from lifestyle-related diseases, the
Japanese government initiated a 10-y national health promotion
campaign called Health Japan 21 in 2000 [6]. In this campaign, 59
indicators were established to monitor and improve the manage-
ment of risk factors and diseases such as diet, smoking, and
diabetes. However, the performance of Health Japan 21 was not
necessarily satisfactory: there was progress on 60% of the 59
indicators, including decreasing daily salt intake, while deteriora-
tion or no improvement was observed for the remaining 40%, for
example, the prevalence of overweight and obesity decreased in
women aged 40–60 y but increased in men aged 20–60 y [7].
Success of national health promotion campaigns may partly
depend on whether the stewardship of central and local
governments exists for coordinating diverse activities and investing
resources in priority areas with reference to scientific evidence on
the disease burden attributable to modifiable risk factors. Although
a number of past studies have quantified population-attributable
fractions or impacts on life expectancy for individual risk factors in
Japan [8–16], no study to our knowledge has used a single
comprehensive framework to assess and compare these impacts
across multiple risk factors.
In the present study, we therefore aimed to provide the most
comprehensive and comparative assessment of preventable risk
factors for mortality from non-communicable diseases and injuries
in the Japanese adult population. We employed a comparative risk
assessment strategy to quantify contributions of health risks to
disease outcomes [17,18]. This standard systematic approach has
already been applied to examine the burden of disease and injury
across major risk factors in a few other countries [19–22]. Using
national data sources on risk exposures and cause-specific
mortality, as well as epidemiologic evidence on their causal
association from large-scale prospective studies and meta-analyses
in Japan, this analysis identifies the most important risk factors for
deaths and life expectancy at the population level; the results could
inform policymakers of which risk factors need to be prioritized in
formulating and revising health policies and programs.
Methods
We estimated the number of deaths that would have been saved
in 2007 if multiple risk factors had been controlled at their optimal
levels as determined by a theoretical-minimum-risk exposure
distribution. To quantify and compare the mortality attributable
to excess health risks, we used comparative risk assessment
methods that have been described in detail elsewhere [18,20]. To
summarize, we first calculated the population-attributable fraction
of cause-specific mortality for each risk factor, which measures a
proportional reduction in mortality that would be achieved if risk
factor exposures of a population shifted to an alternative
counterfactual distribution that is more favorable. We used the
following formula to calculate population-attributable fractions for
continuous exposure variables:
Population   attributable fraction~
ð
x
RR x ðÞ Px ðÞ dx{
ð
x
RR x ðÞ P0 x ðÞ dx
ð
x
RR x ðÞ Px ðÞ dx
,
ð1Þ
where P(x) and P9(x) are actual and counterfactual distributions of
exposure in the population, respectively, and RR(x) is the relative
risk of mortality at exposure level x. The first and second terms in
the numerator of this equation represent the total risk of mortality
weighted by exposures in the population under current and
counterfactual distributions, respectively. This approach allowed
us to compute effects of all nonoptimal exposures of individuals for
all risk factors in a consistent and comparable way [21]. For risks
measured in multiple categories, we used the following generalized
formula to calculate population-attributable fractions:
Population{attributable fraction~
X n
i~1
Pi(RRi{1)
X n
i~1
Pi(RRi{1)z1
, ð2Þ
where i signifies the level of individual categories (i=1,…, n).
We then multiplied the number of cause-specific deaths by
population-attributable fractions to estimate mortality from
diseases (causes of death) associated with each risk factor. The
number of deaths attributable to a single risk factor was summed
across different causes to obtain the total number of deaths
attributable to that risk factor. The number of deaths from a single
cause, however, could not be added across risk factors, because
they may be causally related and we did not account for such
relationships in the estimation of population-attributable fractions
of individual risk factors.
We conducted all analyses separately by sex, using Stata version
11 (StataCorp). We restricted analyses to individuals aged 30 y
and over, because the number of deaths from non-communicable
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aged 20 to 29 y when estimating deaths from external causes
attributable to alcohol use, because the burden was assumed to be
substantial in this age group.
Mortality Data
We obtained data on the number of cause-specific deaths in
2007 from vital records [23]. We applied algorithms developed for
the Global Burden of Disease 2010 Study to redistribute ill-defined
codes (e.g., cardiac arrest, heart failure, and senility) on death
certificates that were not supposed to be underlying causes of
death [24,25]. This method enabled us to obtain valid, reliable,
and comparable data on cause-specific mortality by ensuring
consistency and resolving changes across revisions of the
International Statistical Classification of Diseases and Related Health
Problems.
Selection of Risk Factors and Diseases
We included 16 risk factors in this analysis (Table 1). In the
selection of risk factors paired with their relevant diseases or
injuries, we employed the criteria of a previous study: (i) an
availability of evidence on causality or association from high-
quality epidemiological studies, (ii) an existence of interventions to
modify exposures, and (iii) an availability of data on risk exposures
from nationally representative surveys or large population studies
[20]. We also included infection by several agents—hepatitis B
virus, hepatitis C virus, the bacterium Helicobacter pylori, human
papillomavirus, and human T-lymphotropic virus type 1 (HTLV-
1)—because they are important risk factors for cancer deaths in
Japan [26,27].
Measures and Data Sources of Risk Factor Exposures
Table 2 lists measurements and data sources for the risk
factor exposures used in this analysis, and Table 3 shows their
basic statistics by sex and age group in 2007. With the
exception of tobacco smoking, infections, and alcohol use
related to deaths from traffic road accidents, we used individual
records from the National Health and Nutrition Survey
(NHNS) in 2007. NHNS was a survey based on a nationally
representative probabilistic sample to provide data on the
health and nutritional status of the Japanese population. This
survey included an in-person interview on medication use and
lifestyle-related risk factors, a physical examination by health
care professionals, and self-administered questionnaires on diet
and lifestyle [28].
We used self-reports to quantify exposures to physical inactivity
and alcohol use, while we used measured data for other risk
factors. In the physical examination for the 2007 NHNS, a blood
test was intended to be conducted more than 4 h after a meal,
although a number of blood samples were actually drawn less than
4 h after a meal. Because fasting plasma glucose was the unit for
relative risk for high blood glucose adopted in the present study,
we applied the following conversion equation proposed by the
Committee of the Japan Diabetes Society [29,30] to predict
equivalents of fasting plasma glucose from measurements of
hemoglobin A1c:
Table 1. Risk factors and disease outcomes included in the study.
Risk Factor Disease Outcomes
High blood glucose IHD, stroke, diabetes mellitus
High LDL cholesterol IHD, ischemic stroke
High blood pressure IHD, stroke, hypertensive diseases, other cardiovascular diseases
a
Overweight/obesity IHD; ischemic stroke; hypertensive disease; postmenopausal breast, colon, corpus uteri, kidney, and pancreatic
cancers; diabetes mellitus
Alcohol use IHD; ischemic stroke; hemorrhagic stroke; hypertensive diseases; cardiac arrhythmias; cancers of breast, colorectal,
esophagus, mouth, liver, larynx, pharynx, and selected other sites
b; diabetes mellitus; liver cirrhosis; acute and chronic
pancreatitis; road traffic injuries; falls; homicide and suicide; other injuries
Tobacco smoking IHD; stroke; aortic aneurysms and dissection; diabetes mellitus; lung, esophagus, mouth, pharynx, stomach, liver,
pancreas, cervix, bladder, kidney, and other urinary cancers; leukemia; chronic obstructive pulmonary disease; lower
respiratory tract infections; asthma; tuberculosis
Physical inactivity IHD, ischemic stroke, breast and colon cancers, diabetes mellitus
High dietary trans fatty acids IHD
Low dietary polyunsaturated fatty acids IHD
High dietary salt IHD, stroke, hypertensive disease, other cardiovascular diseases
a, stomach cancer
Low intake of fruit and vegetables IHD; ischemic stroke; colorectal, esophagus, lung, mouth, pharynx, and stomach cancers
Hepatitis B virus Liver cancer
Hepatitis C virus Liver cancer
H. pylori Stomach cancer
Human papillomavirus Cervix uteri cancer
HTLV-1 Adult T-cell lymphoma/leukemia
aThis category includes rheumatic heart disease, endocarditis, cardiomyopathy, aortic aneurysms, peripheral vascular disorders, and other ill-defined cardiovascular
diseases.
bThis category includes International Statistical Classification of Diseases and Related Health Problems, 10th edition (ICD-10) codes D00–D24 (except D09.9), D26–D37
(except D37.9), and D38–D48 (except D38.6, D39.9, D40.9, D41.9, and D48.9).
IHD, ischemic heart disease.
doi:10.1371/journal.pmed.1001160.t001
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where hemoglobin A1cJDS is a value standardized by calibrators
provided by the Japan Diabetes Society and lower than an
internationally used value by around 0.4% [29]. As a minor
adjustment, we further deducted from this equation a difference in
means between predicted fasting plasma glucose and measured
casual plasma glucose among 165 participants in the 2007 NHNS
who had fasted for more than 8 h (6.4 mg/dl).
In the NHNS, health care professionals measured the blood
pressure of seated persons in their right upper arm after 5 min of
rest, using a Riva-Rocci mercury manometer. For a trend analysis
of cardiovascular mortality attributable to high blood pressure,
which is described below, we used the National Nutrition Surveys
for 1980–2002 and the NHNS for 2003–2007. These surveys took
only one blood pressure measurement per individual until starting
to collect two measurements per individual in the 2000 survey. We
therefore used a single measurement for the surveys in 1980–1999
and the second measurement for the 2000–2007 surveys. We
excluded pregnant or breastfeeding women from the analysis of
blood pressure.
For dietary risk exposure variables, dieticians visited house-
holds to distribute questionnaires and explain the survey method
for diet and lifestyle. Household representatives weighed and
recorded the quantity of each food item consumed for one day
(excluding holidays). Dieticians visited households again during
the survey period to check and correct completed question-
naires. We estimated intakes of dietary trans fatty acids using
conversion factors of food items provided by the Cabinet of
Japan Food Safety Committee [31]. Considering that nutrition
intakes are correlated with energy intake determined by body
size, physical activity, and metabolic efficiency, we adjusted
intakes of fruit, vegetables, and dietary sodium for total energy
intake with a simple linear regression equation having nutrient
intake as a dependent variable and total caloric intake as an
Table 2. Measurements, data sources, and alternative distributions of risk exposures.
Risk Factor, Exposure Metric, Data Source
a Optimal Guidelines/National Goals
High blood glucose
Fasting plasma glucose (mmol/l) 4.9 (0.3) 5.6 (0.3) [66]
High LDL cholesterol
LDL cholesterol (mmol/l) 2.0 (0.4) 3.1 (0.7) [54]
High blood pressure
Systolic blood pressure (mm Hg) 115 (6) 130 (7) [53]
Overweight/obesity
Body mass index (kg/m
2) 21 (1) 22 (1) [67]
Alcohol use
Current alcohol consumption volumes and patterns No alcohol use
b
Alcohol-related road traffic accidents, national road accident data, 2004 [40] No alcohol use
Tobacco smoking
Smoking impact ratio, vital statistics 2007 data [23–25], pooled cohort studies [15,35,36] No smoking
Physical inactivity
Intensity of physical activity Highly active
High dietary trans fatty acids
Percent of total calories from dietary trans fatty acids 0.5 (0.05)
Low dietary polyunsaturated fatty acids
Percent of total calories from dietary polyunsaturated fatty acids 10 (1)
High dietary salt
Dietary sodium adjusted for total calories (g/d) 0.5 (0.05) 10 (1) [7]
Low intake of fruit and vegetables
Dietary fruit and vegetable intake adjusted for total calories (g/d) 600 (50) 350 (29) [7]
Hepatitis B virus
Seropositivity for hepatitis B surface antigen, blood donors’ cohort, 1991–1993 [37] No infection
Hepatitis C virus
Seropositivity for antibody to hepatitis C, blood donors’ cohort, 1991–1993 [37] No infection
H. pylori
Seropositivity for anti–H. pylori immunoglobulin G, multi-center study, late 1990s [38] No infection
Values are means, with standard deviations in parentheses.
aWe obtained exposure data from the 2007 National Health and Nutrition Survey [28] unless stated otherwise.
bThe optimal category for liver cancer and suicide was ‘‘occasional drinkers’’ because previous studies used it as the reference category for estimation of relative risks.
doi:10.1371/journal.pmed.1001160.t002
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were computed as the sum of residuals from the regression
model and the expected nutrient intake for a person with mean
caloric intake.
We used a smoking impact ratio as a more reliable indicator of
accumulated exposure to tobacco smoking than the prevalence of
current smokers. The smoking impact ratio was defined as total
lung cancer mortality in excess of never-smokers in a study
Table 3. Exposure to risk factors by sex and age group in 2007.
Sex, Risk Factor Age
30–44 y 45–59 y 60–69 y 70–79 y $80 y
n
a Mean SE n
a Mean SE n
a Mean SE n
a Mean SE n
a Mean SE
Men
Fasting plasma glucose (mmol/l) 300 5.4 0.1 374 5.7 0.0 411 6.0 0.1 339 5.9 0.0 107 5.9 0.1
LDL cholesterol (mmol/l) 300 3.3 0.0 375 3.4 0.0 413 3.1 0.0 340 3.0 0.0 108 2.9 0.1
Systolic blood pressure (mm Hg) 312 124.2 0.8 394 133.9 0.9 427 140.9 0.9 359 142.2 1.0 116 144.1 1.8
Body mass index (kg/m
2) 673 23.9 0.1 777 23.8 0.1 620 23.8 0.1 470 23.6 0.2 155 22.6 0.3
Dietary TFA (% of total calories) 806 0.3 0.0 858 0.3 0.0 664 0.2 0.0 517 0.2 0.0 179 0.3 0.0
Dietary PUFA (% of total calories) 806 5.7 0.1 858 5.6 0.1 664 5.3 0.1 517 5.1 0.1 179 5.0 0.1
Dietary SFA (% of total calories) 806 6.8 0.1 858 6.2 0.1 664 5.7 0.1 517 5.6 0.1 179 5.9 0.2
Dietary salt intake (g/d) 806 11.4 0.2 858 12.3 0.2 664 12.6 0.2 517 12.2 0.2 179 10.9 0.3
Fruit and vegetable intake (g/d) 804 288.6 6.0 856 342.5 6.6 663 432.3 8.8 515 446.8 9.6 178 463.5 15.9
Never or former drinkers (%)
b 850 26.6 1.5 950 25.9 1.4 699 28.9 1.7 525 40.8 2.1 184 55.4 3.7
Alcohol-related accidents/four-wheel
vehicle road traffic accidents,
2004 (%) [40]
c
1.7 1.7 1.7 1.7 1.7
Have intense physical activity (%) 808 34.8 1.7 869 34.5 1.6 667 28.8 1.8 518 42.1 2.2 179 21.8 3.1
Never or former smokers (%) 850 45.2 1.7 946 53.6 1.6 698 65.9 1.8 524 78.6 1.8 184 82.1 2.8
Smoking impact ratio 0.0 0.6 0.5 0.5 0.7
Hepatitis B virus (%) [37] 0.9 0.9 0.9 0.6 0.6
Hepatitis C virus (%) [37] 0.6 1.6 2.6 7.9 7.9
H. pylori (%) [38] 23.6 47.4 66.1 73.4 72.6
Women
Fasting plasma glucose (mmol/l) 563 5.3 0.0 620 5.7 0.0 523 5.9 0.0 408 5.9 0.0 154 5.9 0.1
LDL cholesterol (mmol/l) 565 2.9 0.0 622 3.4 0.0 523 3.5 0.0 410 3.3 0.0 154 3.2 0.1
Systolic blood pressure (mm Hg) 527 112.4 0.6 652 128.1 0.8 560 135.8 0.8 433 138.9 0.8 170 143.2 1.4
Body mass index (kg/m
2) 874 21.4 0.1 905 22.7 0.1 723 23.3 0.1 534 23.1 0.2 248 22.4 0.3
Dietary TFA (% of total calories) 955 0.4 0.0 957 0.3 0.0 762 0.3 0.0 561 0.3 0.0 285 0.2 0.0
Dietary PUFA (% of total calories) 955 5.9 0.1 957 6.0 0.1 762 5.6 0.1 561 5.3 0.1 285 5.3 0.1
Dietary SFA (% of total calories) 955 7.8 0.1 957 7.0 0.1 762 6.2 0.1 561 5.9 0.1 285 5.7 0.2
Dietary salt intake (g/d) 955 9.6 0.1 957 10.7 0.1 762 10.9 0.2 561 10.6 0.2 285 10.0 0.2
Fruit and vegetable intake (g/d) 951 346.0 6.1 957 460.2 7.6 761 541.3 9.0 561 522.8 9.7 284 490.3 13.2
Never or former drinkers (%)
b 1,014 54.9 1.6 1,047 61.1 1.5 795 75.5 1.5 579 83.4 1.5 310 88.7 1.8
Alcohol-related accidents/four-wheel
vehicle road traffic accidents,
2004 (%) [40]
c
1.7 1.7 1.7 1.7 1.7
Have intense physical activity (%) 958 36.3 1.6 959 40.9 1.6 765 39.0 1.8 562 45.4 2.1 286 21.3 2.4
Never or former smokers (%) 1,014 81.8 1.2 1,047 87.1 1.0 794 92.1 1.0 579 96.5 0.8 310 95.5 1.2
Smoking impact ratio 0.0 0.1 0.2 0.2 0.2
Hepatitis B virus (%) [37] 0.5 0.5 0.5 0.6 0.6
Hepatitis C virus (%) [37] 0.4 1.6 3.5 7.0 7.0
H. pylori (%) [38] 23.6 47.4 66.1 73.4 72.6
aSample size in the National Health and Nutrition Survey in 2007.
bFor those aged 20–29 y, the mean (standard error) was 40.4 (2.7) in men (n=324) and 53.9 (2.5) in women (n=395).
cReported for the total age group of both sexes combined.
PUFA, polyunsaturated fatty acids; SE, standard error; SFA, saturated fatty acids; TFA, trans fatty acids.
doi:10.1371/journal.pmed.1001160.t003
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current smokers in a reference population [33,34]. We used the
following formula to calculate smoking impact ratios by age group
and sex:
Smoking impact ratio~
CLC{NLC
S 
LC{N 
LC
|
N 
LC
NLC
, ð4Þ
where CLC and NLC denote lung cancer mortality of the total
population and never-smokers, respectively, in a study population
(i.e., the Japanese population), and S 
LC and N 
LC signify lung
cancer mortality among current smokers and never-smokers,
respectively, in a reference population. We obtained total lung
cancer mortality from the redistributed data of vital records
described above. Our reference population was residents included
in a pooled study of three large-scale cohorts in Japan [15,35,36].
Because we also adopted never-smokers’ lung cancer mortality in
the Japanese population from this pooled study, NLC and N 
LC
were equivalent to each other in our analysis.
We obtained data on the prevalence of infections with hepatitis
B and C viruses and the bacterium H. pylori from epidemiological
studies undertaken in Japan in the 1990s [37,38]. Assuming that
infection rates do not vary within birth cohorts over time, we
applied infection rates by age group in the 1990s to those of
corresponding age in 2007. For example, the infection rate for
hepatitis B virus in men aged 60–69 y in 2007 was that of men
aged 45–54 y in 1991–1993. We considered that all deaths from
cervix uteri cancer and adult T-cell lymphoma/leukemia were
caused by infections with human papillomavirus and HTLV-1,
respectively [26,39].
In order to measure exposure levels of alcohol use related to
deaths from road traffic injuries, we employed a proportion of
alcohol-impaired driving, which was defined as driving with breath
alcohol concentrations above 0 mg/l, to the total number of cases
of road traffic accidents involving four-wheeled vehicles and
motorcycles in 2004 (1.7%). We obtained this figure from a past
study on alcohol concentrations in the breath of drivers, which
used a national dataset prepared by the Japan Institute for Traffic
Accident Research and Data Analysis [40].
Selection of Relative Risks
Tables S1, S2, S3, S4, S5, S6, S7 provide details of relative risks
used in this analysis. We conducted a literature review of
prospective studies evaluating effects of risk factors on cause-
specific deaths in Japan. Strategies for the database search
involved contacting authors of key reports and leading experts in
the field, and we critically appraised the identified literature. Our
motive for undertaking the literature search was to identify
evidence from past studies in the Japanese population to be backed
up with pooled evidence establishing causalities or associations
from the Global Burden of Disease Study [20]. Criteria for the
selection of evidence for the Japanese population were: (i) pooled
or individual estimates from large-scale prospective observational
studies and (ii) confirming causalities or associations that had been
already established in past studies. When there was no study for
the Japanese population satisfying these conditions, we sought
evidence from the Asia-Pacific Cohort Studies Collaboration. If we
could not find evidence from this source, then we adopted relative
risks identified in the Global Burden of Disease Study. We
considered relative risks to be null if they were statistically
insignificant. In addition, we had to restrict the source of evidence
on relative risks for tobacco smoking to the pooled analysis of
large-scale cohorts in Japan, because we used their estimates of
current smokers’ and never-smokers’ lung cancer mortality of a
reference population to calculate smoking impact ratios. We
excluded mortality from tuberculosis and diabetes mellitus
associated with tobacco smoking, because the studies did not
examine these causes.
Counterfactual Distributions of Risk Exposures
As an alternative distribution of risk exposures, we used an
optimal distribution in which harmful effects of each risk factor on
morbidity and mortality would be minimized in a population (i.e.,
a theoretical-minimum-risk exposure distribution). With the
exception of infections, we obtained information on theoretical-
minimum-risk exposure distributions from a previous study in the
United States (Table 2) [20].
In the analysis of gains in life expectancy and probabilities of
death, we also investigated alternative counterfactual distributions
of risk exposures that followed recommendations of clinical
guidelines and goals of Health Japan 21. This analysis enabled
quantification of potential health gains that would be more
realistic than theoretical minimums. We included risk factors in
this part of our analysis only if specific control targets were
available from these sources and units of measurement corre-
sponded to those of relative risks (Table 2). In order to obtain
counterfactual distributions for numerical risks, we used their
control threshold as the mean and applied the coefficient of
variation to estimate the standard deviation.
The relationship between dietary salt intake and cardiovascular
mortality was based on a convincing effect of high dietary salt on
systolic blood pressure that was estimated from a meta-analysis of
dietary trials (Table S6) [20]. In order to obtain hazards of excess
dietary salt intake on cardiovascular death, we first estimated the
decrease in systolic blood pressure associated with a reduction in
dietary salt intake to individual optimal levels and then applied
relative risks of high systolic blood pressure for relevant
cardiovascular diseases (Table S1).
Effects on Life Expectancy and Probabilities of Death
We translated mortality changes into gains in life expectancy at
40 y of age to understand the potential impact of the management
of risk factors on longevity. We constructed life tables using
observed age-specific mortality rates and mortality that would be
expected if risk factor exposures were controlled at alternative
levels. We took the differences between these values as showing life
expectancy gains that would occur when shifting from an actual
risk factor exposure to a counterfactual. We also calculated effects
on probabilities of dying between the ages of 15 and 60 y (45q15)
and between 60 and 75 y (15q60).
Joint Effects of Multiple Risk Factors for Cardiovascular
Mortality
We estimated joint effects of multiple risk factors on excess
mortality from cardiovascular diseases and the additional life
expectancy at age 40 y that would be achieved under counterfac-
tual distributions. Risk factors included in this part of the analysis
were high body mass index, high blood pressure, and high
concentrations of blood glucose and low density lipoprotein (LDL)
cholesterol. We took account of high dietary sodium intake to
compensate for its indirect effect through elevated blood pressure,
using the steps described above. We also adopted a 50% reduction
of the excess risk of high body mass index on cardiovascular deaths
to incorporate a mediation of its associations through other risk
factors [21]. We used an additive excess risk scale to correct for
correlations of these risk factors and calculate joint relative risks at
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elsewhere [21]. We summed the combined relative risks for
individual records to compute population-attributable fractions for
the joint effects of these cardiovascular risks.
Long-Term Trends in Attributable Deaths
To examine contributions of the management of modifiable risk
factors to the improvement of life expectancy over time, we
estimated the number of deaths from cancers attributable to
tobacco smoking and deaths from stroke associated with high
blood pressure from 1980 to 2007. We employed the algorithm
described above to obtain consistent mortality data throughout
this period, from which we used total lung cancer mortality in each
year to calculate smoking impact ratios over time. For the analysis
of high blood pressure and stroke, we excluded people over 80 y of
age because the sample size was insufficient. We also incorporated
the above-mentioned mediated effects of dietary sodium intake
through raised blood pressure at the individual level.
Uncertainty Analyses
We conducted statistical simulation to deal with the uncertainty
that was introduced by using sample estimates for risk exposures
and relative risks [41]. To account for sampling variability, we
randomly drew 1,000 sets of values of all components based on
samples. In each sequential step of the simulation, we drew for
each age–sex group: (i) a random sample of participants in the
2007 NHNS with replacement to obtain the original sample size of
those who had no missing value for each risk factor, (ii) a relative
risk for each risk–disease pair from a log-normal distribution with
means and standard deviations reported in epidemiological
studies, (iii) coefficients of the regression of hemoglobin A1c on
fasting plasma glucose from a normal distribution with standard
deviations that we calculated from information given in a past
study (1.0 for the constant term and 0.2 for the coefficient of
hemoglobin A1c) [30], (iv) the difference in means between
predicted fasting plasma glucose and measured casual plasma
glucose in the 2007 NHNS from a normal distribution with mean
of 6.4 mg/dl and standard deviation of 1.1 mg/dl that we
estimated from the survey data, (v) the proportion of the excess
risk of body mass index mediated through systolic blood pressure
and fasting plasma glucose from a normal distribution with mean
of 0.5 and standard deviation of 0.1 [21], and (vi) lung cancer
mortality of current smokers and never-smokers from a normal
distribution with means and standard deviations estimated from
the pooled analysis of Japanese cohorts [15,35]. We used each
sampled set of risk exposures and relative risks to compute
population-attributable fractions, mortality attributable to each
risk factor or a combination of risk factors, and changes in life
expectancy under counterfactual distributions. We defined a 95%
confidence interval (CI) by a span across the estimates of each
outcome at the 2.5th and 97.5th percentiles of the 1,000
simulations.
Results
Contributions of Health Risks to Cause-Specific Mortality
in 2007
Tables S8 and S9 provide population-attributable fractions of
the 16 modifiable risk factors and a combination of physiological
risk factors for mortality from non-communicable diseases and
injuries by age group and sex in 2007. These fractions cannot to be
summed across risk factors for a single cause of death, because
causal relationships between risk factors are not considered in the
analysis of individual risk factors.
Under the theoretically minimum counterfactuals listed in
Table 2, tobacco smoking and high blood pressure were the two
major single contributors to the number of deaths from non-
communicable diseases and injuries (Table 4). Among the total of
960,000 deaths from causes included in this study, tobacco
smoking was associated with 129,000 deaths (95% CI: 115,000–
154,000). Approximately three-quarters of these deaths occurred
in men (95,000 deaths, 95% CI: 88,000–103,000), although the
attributable mortality was still substantial for women (34,000
deaths, 95% CI: 23,000–57,000). In men, 70% of deaths
attributable to this risk factor were caused by cancers and took
place among those aged 45–79 y. In women, cardiovascular
diseases and cancers accounted for 42% and 36%, respectively, of
the mortality attributable to tobacco smoking. By disease subtypes
for sexes combined, lung cancer was the leading cause (42,000
deaths, 95% CI: 39,000–45,000), followed by ischemic heart
disease (27,000 deaths, 95% CI: 19,000–42,000) and chronic
obstructive pulmonary disease (13,000 deaths, 95% CI: 9,000–
16,000).
High blood pressure was associated with 104,000 cardiovascular
deaths (95% CI: 86,000–119,000) in 2007. This was the greatest
risk factor for cardiovascular mortality of all risk factors included
in this analysis, and the mortality burden was shared evenly
between the sexes. A majority of deaths attributable to high blood
pressure occurred among people aged 70 y and over (85,000
deaths) and were caused by stroke (47,000 deaths, 95% CI:
38,000–56,000) or ischemic heart disease (28,000 deaths, 95% CI:
15,000–39,000).
Although the numbers of attributable deaths for other
physiological, lifestyle, dietary, and infectious factors were small
when compared to those for tobacco smoking and high blood
pressure, most of these other factors were associated with tens of
thousands of deaths from non-communicable diseases and
external causes. Physical inactivity was associated with 52,000
deaths (95% CI: 47,000–58,000), and 75% of them occurred
among people aged 70 y and older. Ischemic heart disease was
the major cause of mortality attributable to this risk factor (31,000
deaths, 95% CI: 28,000–35,000). High blood glucose was
associated with 34,000 deaths (95% CI: 26,000–43,000), of
which 75% occurred among people aged 70 y and over and 68%
were caused by ischemic heart disease. High dietary salt intake
was associated with 19,000 cardiovascular deaths (95% CI:
16,000–22,000), which were included in cardiovascular mortality
attributable to high blood pressure, and there were 15,000 deaths
from stomach cancer (95% CI: 9,000–20,000). Seventy-six
percent of deaths attributable to this risk factor occurred among
people aged 70 y and over.
Alcohol use was associated with 31,000 deaths (95% CI:
27,000–35,000) from non-communicable diseases and injuries,
84% of which occurred among men. A major cause of death
attributable to this risk factor was liver cirrhosis (11,000 deaths,
95% CI: 10,000–12,000), followed by liver cancer (6,000 deaths,
95% CI: 4,000–8,000), esophagus cancer (5,000 deaths, 95% CI:
4,000–5,000), and colon cancer (4,000 deaths, 95% CI: 4,000–
5,000). Alcohol use was associated with 3,000 (95% CI: 2,000–
5,000) out of 83,000 deaths of people aged 20 y and over from
external causes included in this study. Two thousand deaths were
from suicide (95% CI: 1,000–4,000), and there were fewer than
1,000 deaths each attributable to falls, road traffic accidents,
homicide, and other injuries. Most of the suicide deaths
attributable to alcohol use occurred among men, particularly
those aged 30 to 59 y (71%).
Infection with H. pylori was associated with 31,000 deaths from
gastric cancer in 2007 (95% CI: 27,000–34,000). Seventy-two
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Sex, Risk Factor Total Cardiovascular Cancer Diabetes Mellitus Respiratory Other NCD Injuries
Sexes combined
High blood glucose 34.1 (26.4, 43.1) 27.2 (19.5, 36.2) 6.9
High LDL cholesterol 23.9 (16.7, 31.2) 23.9 (16.7, 31.2)
High blood pressure 103.9 (86.0, 119.1) 103.9 (86.0, 119.1)
High body mass index 19.0 (16.1, 21.9) 13.8 (11.1, 16.4) 4.1 (3.4, 4.9) 1.1 (0.8, 1.3)
Alcohol use 30.6 (27.5, 34.7) 22.0 (24.0, 0.0) 18.2 (16.2, 20.8) 20.1 (20.1, 20.1) 11.6 (10.6, 12.7) 2.9 (1.9, 4.6)
Tobacco smoking 128.9 (115.5, 153.6) 33.4 (25.4, 48.8) 77.4 (72.3, 83.9) 18.1 (12.6, 26.4)
Physical inactivity 52.2 (46.7, 57.7) 42.2 (36.6, 47.6) 9.3 (8.5, 10.0) 0.7 (0.6, 0.9)
High TFA intake 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
Low PUFA intake 21.2 (8.1, 38.7) 21.2 (8.1, 38.7)
High dietary
sodium intake
34.0 (27.3, 39.4) 19.0 (16.1, 22.3) 14.9 (8.8, 19.6)
Low fruit and
vegetable intake
8.9 (6.7, 10.8) 5.1 (3.3, 6.7) 3.8 (2.5, 4.9)
Hepatitis B virus 11.6 (9.8, 13.5) 11.6 (9.8, 13.5)
Hepatitis C virus 23.0 (21.3, 24.5) 23.0 (21.3, 24.5)
H. pylori 30.6 (27.2, 33.5) 30.6 (27.2, 33.5)
Human papillomavirus 2.6 2.6
HTLV-1 1.1 1.1
Joint risk
a 157.0 (144.0, 173.4) 157.0 (144.0, 173.4)
Men
High blood glucose 17.2 (12.7, 22.2) 14.3 (9.8, 19.3) 2.9
High LDL cholesterol 12.2 (8.1, 15.9) 12.2 (8.1, 15.9)
High blood pressure 50.1 (39.9, 58.5) 50.1 (39.9, 58.5)
High body mass index 12.1 (10.0, 14.3) 9.6 (7.6, 11.6) 2.0 (1.6, 2.6) 0.5 (0.4, 0.7)
Alcohol use 25.8 (22.6, 29.5) 21.7 (23.7, 0.2) 15.9 (13.7, 18.2) 20.1 (20.1, 20.1) 9.0 (8.2, 9.7) 2.8 (1.7, 4.4)
Tobacco smoking 94.9 (87.7, 103.4) 19.3 (15.4, 24.5) 66.5 (61.8, 71.2) 9.1 (6.8, 10.9)
Physical inactivity 25.9 (22.8, 29.4) 21.0 (18.1, 24.4) 4.6 (4.0, 5.1) 0.3 (0.3, 0.4)
High TFA intake 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
Low PUFA intake 12.0 (5.3, 29.3) 12.0 (5.3, 29.3)
High dietary
sodium intake
18.4 (13.0, 22.7) 8.8 (7.3, 10.2) 9.7 (4.4, 13.7)
Low fruit and
vegetable intake
7.6 (5.5, 9.5) 4.3 (2.5, 5.9) 3.3 (2.1, 4.4)
Hepatitis B virus 8.0 (6.6, 9.6) 8.0 (6.6, 9.6)
Hepatitis C virus 14.8 (13.4, 16.1) 14.8 (13.4, 16.1)
H. pylori 20.0 (17.0, 22.4) 20.0 (17.0, 22.4)
HTLV-1 0.6 0.6
Joint risk
a 78.5 (70.8, 87.8) 78.5 (70.8, 87.8)
Women
High blood glucose 16.9 (11.6, 23.3) 12.9 (7.6, 19.3) 4.0
High LDL cholesterol 11.7 (6.5, 18.0) 11.7 (6.5, 18.0)
High blood pressure 53.9 (40.0, 66.9) 53.9 (40.0, 66.9)
High body mass index 6.8 (5.0, 8.9) 4.2 (2.5, 5.9) 2.1 (1.6, 2.6) 0.5 (0.3, 0.8)
Alcohol use 4.8 (3.8, 6.3) 20.3 (20.5, 20.1) 2.3 (1.7, 3.3) 20.0 (20.1, 20.0) 2.6 (2.1, 3.4) 0.2 (0.1, 0.3)
Tobacco smoking 34.0 (22.9, 56.5) 14.1 (7.3, 28.2) 10.9 (8.3, 15.7) 9.0 (4.0, 17.4)
Physical inactivity 26.3 (21.6, 30.9) 21.2 (16.5, 25.9) 4.7 (4.2, 5.2) 0.4 (0.3, 0.5)
High TFA intake 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
Low PUFA intake 9.3 (4.0, 16.1) 9.3 (4.0, 16.1)
High dietary sodium
intake
15.6 (11.3, 19.2) 10.3 (7.7, 13.1) 5.3 (1.9, 7.5)
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older. Infection with hepatitis C virus was associated with 23,000
deaths from liver cancer (95% CI: 21,000–24,000). Forty-five
percent of these deaths were in people aged 70–79 y, including
those born in the early 1930s. For both H. pylori and hepatitis C
virus infections, around 65% of the attributable mortality took
place in men.
High LDL cholesterol was associated with 24,000 cardiovascu-
lar deaths (95% CI: 17,000–31,000), largely from ischemic heart
disease (23,000 deaths, 95% CI: 16,000–30,000). Low dietary
intake of polyunsaturated fatty acids was associated with 21,000
deaths from ischemic heart disease (95% CI: 8,000–39,000), and
47% of these deaths occurred among people aged 80 y and over.
High body mass index was associated with 19,000 deaths (95% CI:
16,000–22,000): 64% of these deaths occurred in men, and
ischemic heart disease was the major cause (11,000 deaths, 95%
CI: 8,000–13,000).
If systolic blood pressure (directly, and indirectly through
dietary salt intake), blood glucose, LDL cholesterol, and body mass
index were controlled jointly to their optimal distributions, i.e.,
theoretical-minimum-risk exposure distributions, 157,000 cardio-
vascular deaths would have been prevented in 2007 (95% CI:
144,000–173,000). The mortality burden attributable to the
combination of these risks was shared equally between the sexes,
and a majority of the burden occurred among people aged 70 y
and older.
Effects of Risk Factors on Life Expectancy and
Probabilities of Death
Japanese life expectancy at age 40 y was 40.4 y for men and
46.8 y for women in 2007 [3]. Figure 1 illustrates gains in life
expectancy at age 40 y and percentage changes in probabilities of
death that would have been expected in 2007 if risk factors had
been controlled to their theoretically minimum distributions
individually or jointly with others. For men, tobacco smoking
was associated with the largest potential increase in life expectancy
at age 40 y (1.8 y, 95% CI: 1.6–1.9), followed by a joint effect of
multiple physiological factors (1.4 y, 95% CI: 1.3–1.6) and single
effects of high systolic blood pressure (0.9 y, 95% CI: 0.7–1.0) and
alcohol use (0.5 y, 95% CI: 0.5–0.6). A considerable part of the
smoking effect (1.2 y, 95% CI: 1.1–1.3) was accounted for by an
expected associated fall in cancer mortality through a decrease in
probabilities of dying between the ages of 15 and 60 (45q15) by
8% (95% CI: 7–10) and between the ages of 60 and 75 (15q60) by
13% (95% CI: 12–14). A drop in cardiovascular mortality through
the joint control of multiple risks was associated with an expected
percentage decrease of 13% (95% CI: 12–15) in 45q15 and 11%
(95% CI: 10–13) in 15q60, while controlling high blood pressure
was associated with an expected fall of 7% both in 45q15 (95% CI:
6–8) and 15q60 (95% CI: 5–8). Decreasing alcohol use was
associated with an expected percentage decrease of 9% (95% CI:
7–11) in 45q15 and 5% (95% CI: 5–6) in 15q60 for men. A
substantial part of the potential change in the probability of death
among young and middle-aged men through moderate drinking
was explained by a fall in mortality from other non-communicable
diseases including liver cirrhosis and liver cancer (4%, 95% CI: 4–
4) and injuries (2%, 95% CI: 1–4).
For women, controlling systolic blood pressure and tobacco
smoking to optimal counterfactuals would have extended life
expectancy at age 40 y by 0.9 y (95% CI: 0.7–1.1) and 0.6 y (95%
CI: 0.4–1.0), respectively. The impact of tobacco smoking on a
probability of death in older women was estimated to be 8% (95%
CI: 5–13), which was comparable to that of high blood pressure
(7%, 95% CI: 6–8). A joint effect of cardiovascular risk factors on
female life expectancy at age 40 y was estimated to be 1.4 y (95%
CI: 1.2–1.7), with a decrease in probability of death of 8% (95%
CI: 7–10) for younger adults and 11% (95% CI: 10–12) for older
ages.
Table 5 shows changes in life expectancy at age 40 y and
probabilities of death under the more practical counterfactuals
defined by clinical guideline recommendations and national goals.
Overall, the gains were less than half of those under theoretically
minimum distributions. In both sexes, life expectancy at age 40 y
would have increased by 0.7 y (95% CI: 0.6–0.9) through the joint
control of cardiovascular risks and by 0.4 y (95% CI: 0.3–0.5)
through reducing systolic blood pressure to the distribution
recommended by clinical guidelines.
Trends in Mortality Attributable to Tobacco Smoking and
High Blood Pressure in 1980–2007
Figure 2 illustrates trends in the number of deaths from cancers
that were attributable to tobacco smoking from 1980 to 2007. A
continuous increase has been observed in men over 70 y old and
women over 80 y old. A fall after a peak around 1995 among men
aged 60–69 y reflected the fact that the lifetime smoking
prevalence reached a peak in the birth cohort of the late 1920s
and decreased in the cohort of the late 1930s [42]. This effect
manifested again as a peak in attributable cancer mortality around
2005, when the birth cohort of the late 1920s was 70–79 y old. A
temporary halt in the increase of cancer deaths attributable to
Sex, Risk Factor Total Cardiovascular Cancer Diabetes Mellitus Respiratory Other NCD Injuries
Low fruit and
vegetable intake
1.3 (0.9, 1.7) 0.8 (0.4, 1.2) 0.5 (0.3, 0.6)
Hepatitis B virus 3.6 (2.8, 4.5) 3.6 (2.8, 4.5)
Hepatitis C virus 8.2 (7.3, 9.0) 8.2 (7.3, 9.0)
H. pylori 10.6 (8.9, 12.0) 10.6 (8.9, 12.0)
Human papillomavirus 2.6 2.6
HTLV-1 0.5 0.5
Joint risk
a 78.5 (66.9, 91.1) 78.5 (66.9, 91.1)
Values in parentheses indicate lower and upper bounds of 95% CI.
aA combination of high blood glucose, high LDL cholesterol, high blood pressure (directly, and indirectly through high dietary salt intake), and high body mass index.
NCD, non-communicable disease; PUFA, polyunsaturated fatty acids, TFA, trans fatty acids.
doi:10.1371/journal.pmed.1001160.t004
Table 4. Cont.
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a reduction in this population group as a result of the 1918
influenza pandemic.
Figure 3 demonstrates trends in the number of deaths from
stroke that were attributable to high blood pressure. Stroke deaths
associated with this risk factor, either directly or indirectly through
high dietary sodium intake, consistently declined for both sexes
under 80 y of age. This favorable trend continued in the 2000s for
women and for men under the age of 60 y, but it ceased for elderly
men by the mid-1990s.
Figure 1. Changes in life expectancy at age 40 y and the probability of death under optimal distributions of risk factors in Japan,
2007. (A) Life expectancy at age 40. (B) Probability of death between 15 and 60 y of age. (C) Probability of death between 60 and 75 y of age. Joint
risk is a combination of high blood pressure (directly, or indirectly through high dietary salt intake), high blood glucose, high LDL cholesterol, and
high body mass index. BMI, body mass index; CVD, cardiovascular disease; NCD, non-communicable diseases; PUFA, polyunsaturated fatty acids; SFA,
saturated fatty acids; TFA, trans fatty acids.
doi:10.1371/journal.pmed.1001160.g001
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To our knowledge, this is the first study in Japan to assess and
compare effects of a comprehensive list of modifiable risk factors
on life expectancy and death from non-communicable diseases
and injuries under the framework of comparative risk assessment.
Our study indicates that major risks for adult mortality from these
causes are tobacco smoking and high blood pressure, as well as a
combination of multiple cardiovascular risks. We also demonstrate
that, over the past 27 y, cancer mortality attributable to tobacco
smoking has increased, especially in the older population, while
stroke death associated with high blood pressure has decreased.
The leading single risk factors for adult mortality from non-
communicable diseases and injuries in Japan, i.e., tobacco
smoking, high blood pressure, physical inactivity, and high blood
glucose concentrations, agree with those in the world and the US
[2,20]. The number of deaths attributable to tobacco smoking for
Japanese men is large relative to the number attributable to high
blood pressure, even compared with the proportion among
American men. This result may be related to a substantially
higher prevalence of male smokers in Japan than in the US for the
past 25 y [43]. Moreover, high body mass index ranks only tenth
for both sexes in Japan, while it is one of the top five contributors
to mortality in other high- and middle-income countries [2]. This
finding reflects the fact that mean body mass index in Japan is low
for the income level of the country [44].
Our estimate of the impact of tobacco smoking on male life
expectancy at age 40 y (1.8 y) was smaller than those of past
cohort studies in Japan. Previous studies showed that, according to
smoking status at the time of the baseline survey, life expectancy
for men aged 40 y in the total population was shorter than that of
never-smokers by around 2.5 y [14,16]. Use of different exposure
measurements may explain part of the difference in estimated
impacts of tobacco smoking between the present and past studies.
We believe that the smoking impact ratio used in our study is
useful for quantifying accumulated smoking risk over a lifetime.
Our results suggest that the threat of tobacco smoking for
mortality is enormous in men and has been increasing over time
through the accumulation of exposure to this risk in the older
population. A previous study showed that lifetime smoking
prevalence was low for the generation born in the late 1930s
who experienced the deprivation in the early postwar years, but
rose thereafter until it peaked for the birth cohort of the 1950s
[42]. These findings imply that, without effective policy interven-
tions, the increasing trend in tobacco-associated mortality may
continue until at least the late 2030s, when the birth cohort of the
late 1950s reaches the age of 80 y. Aiming to decrease the disease
burden related to tobacco smoking in the population, the Japanese
government enacted the Health Promotion Act in 2002 to support
prevention of passive smoking in public places. Based on this
legislation, Health Japan 21 specified four targets for tobacco
smoking: (i) increasing knowledge of the adverse health effects of
smoking, (ii) prohibiting minors from smoking, (iii) strengthening
separation of smoking areas in public spaces and the workplace,
and (iv) dissemination of smoking cessation programs in all
municipalities. A final appraisal of Health Japan 21 concluded that
there was improvement for all of these targets [7]. However, the
prevalence of smoking in the male working population is still high
at around 50%, although it has been gradually declining after the
implementation of a series of antismoking policies. Moreover,
although Japan ratified the World Health Organization Frame-
work Convention on Tobacco Control in 2004, compliance is
lagging behind international standards for smoke-free policies,
bans on advertising, health warnings on cigarette packages, and
antitobacco mass media campaigns [45]. The retail price of the
most popular brand of cigarettes is lower than the average among
high-income countries [45]. The recent tobacco tax increase in
October 2010 was insufficient to induce smokers to give up
Table 5. Changes in life expectancy at age 40 y (e40) and percentage changes in the probability of death between 15 and 60 y of
age (45q15) and between 60 and 75 y of age (15q60) under counterfactual distributions of risk factors defined by clinical
guidelines and national goals.
Risk Factor e40 (Years) 45q15 (Percent) 15q60 (Percent)
Men
High blood glucose 0.1 (0.0, 0.2) 20.1 (21.0, 20.1) 20.7 (21.2, 20.2)
High LDL cholesterol 0.0 (0.0, 0.0) 20.6 (21.3, 20.1) 0.0 (20.1, 0.0)
High blood pressure 0.4 (0.3, 0.5) 21.2 (22.1, 20.3) 23.0 (23.7, 22.3)
High body mass index 0.1 (0.1, 0.2) 21.8 (22.2, 21.4) 21.6 (22.0, 21.2)
High dietary salt intake 0.0 (0.0, 0.0) 23.4 (20.2, 0.0) 22.4 (20.5, 20.1)
Low fruit and vegetable intake 0.0 (0.0, 0.0) 20.5 (20.9, 20.3) 0.0 (0.0, 0.0)
Joint risk
a 0.7 (0.6, 0.9) 25.8 (28.4, 25.1) 26.0 (27.4, 25.2)
Women
High blood glucose 0.1 (0.1, 0.2) 20.2 (20.9, 0.0) 20.7 (21.2, 20.2)
High LDL cholesterol 0.0 (0.0, 0.0) 20.4 (20.8, 0.0) 20.4 (20.7, 20.3)
High blood pressure 0.4 (0.3, 0.5) 0.0 (0.0, 0.0) 22.8 (23.5, 22.1)
High body mass index 0.0 (0.0, 0.1) 20.1 (20.4, 0.0) 21.1 (21.5, 20.8)
High dietary salt intake 0.0 (0.0, 0.0) 20.2 (20.3, 20.1) 20.4 (20.5, 20.2)
Low fruit and vegetable intake 0.0 (0.0, 0.0) 0.0 (20.1, 0.0) 0.0 (0.0, 0.0)
Joint risk
a 0.7 (0.6, 0.9) 23.1 (22.6, 21.0) 25.6 (26.6, 24.9)
Values in parentheses indicate lower and upper bounds of 95% CI.
aA combination of high blood glucose, high LDL cholesterol, high blood pressure (directly, and indirectly through high dietary salt intake), and high body mass index.
doi:10.1371/journal.pmed.1001160.t005
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control policies is slow, largely because Japanese society is
relatively tolerant of this unhealthy behavior. In order to improve
the health of the population, policymakers need to implement
further stringent antismoking measures that appropriately assess
the health impacts of smoking on non-smokers as well as on the
smokers themselves.
Our study suggests that a decrease in population blood
pressure partly accounts for a reduced mortality from stroke at
least since 1980, although the downward trend leveled off for
elderly men in the early 1990s. Stroke mortality started
decreasing in the late 1960s and has been the major contributor
to the increase of life expectancy in Japan [4]; our finding backs
up the idea that a reduction in population blood pressure has
contributed to improved longevity. Potential key factors for the
decline of blood pressure in the Japanese population may include
increased use of blood-pressure-lowering drugs among patients
with hypertension, and a reduction in dietary salt intake [46].
These successes may be attributed to the support of the national
government for community-based programs for hypertension
control that were proven to be effective in pilot studies conducted
in the 1960s and 1970s [47]. In 1982, a national act on health
and medical care was enacted that required all municipalities to
provide residents aged 40 y and over with health screening and
Figure 2. Cancer deaths attributable to tobacco smoking, by age group, 1980–2007. Data for (A) men and (B) women.
doi:10.1371/journal.pmed.1001160.g002
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[47].
Despite the decrease in stroke mortality attributable to high
blood pressure, this is still the major risk factor for cardiovascular
mortality in Japan. The management of high blood pressure is not
adequate even under the practical standards of domestic clinical
guidelines. In 2007, less than 60% of hypertensive patients took
antihypertensive medication daily, and only 20% had their blood
pressure controlled [48]. These treatment coverage and control
rates are substantially lower than those in the US [48]. Previous
studies pointed out that an acceptance of higher control thresholds
of blood pressure among physicians [49] and insufficient treatment
regimens [50] might partly explain the poor control of blood
pressure with antihypertensive drugs in Japanese clinical practice.
A thorough investigation is necessary to understand what makes
the quality of care for hypertension so low at the population level,
including investigating adherence of patients to prescriptions.
Furthermore, lowering dietary sodium intake is crucial for
decreasing blood pressure as well as mortality from stomach
cancer in Japan. The Japanese diet is traditionally high in salt,
which mainly comes from soy sauce, miso soup, and salted
vegetables and fish [51]. Although Health Japan 21 was successful
in decreasing average daily salt intake from 13.5 g in the baseline
year to 10.7 g in 2009 [7], it is well above the global target of 5 g/
Figure 3. Stroke deaths attributable to high blood pressure, by age group, 1980–2007. Data for (A) men and (B) women.
doi:10.1371/journal.pmed.1001160.g003
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industrial sector on ingredient labeling for consumers and
reducing sodium content in commercially processed products are
essential.
Another key finding of our study is that a considerable number of
deaths from cardiovascular diseases would be prevented through
joint control of multiple risk factors in Japan. In addition to the
traditional approach of focusing on single risk factors, health
education and effective treatment based on absolute risk have great
potential for improving primary and secondary prevention of
cardiovascular mortality. Our results support current domestic
efforts to target high-risk populations, such as cardiovascular risk
stratification according to categories of multiple risks [53,54] and
the development of risk assessment charts for Japanese people [55].
Our study suggests that physical inactivity contributes to a
substantial mortality from non-communicable diseases in Japan.
Lack of exercise is common: in 2008, two-thirds of the Japanese
adult population engaged in less than 30 min of moderate activity
per week or less than 20 min of vigorous activity three times per
week [56]. Considering global efforts to promote physical activity
for the prevention of non-communicable diseases [57], it is
important to strengthen policies for improving public understand-
ing of the role of physical training in disease prevention, and
provide support for individual’s efforts to start having regular
exercise.
Our results suggest that mortality from external causes, such as
suicide and traffic accidents, associated with alcohol use is fairly
small in Japan. For suicide, relative risks of alcohol use were
insignificant, except for heavy drinking, in a large Japanese cohort
study [58]. Major reasons for suicide in the male working
population are psychiatric disorders and economic reasons such
as business failure, unemployment, and debts [59], which suggest
that direct risk factors for deaths from suicide are psychosocial,
and alcohol use itself may have only an indirect effect. Regarding
road traffic accidents, it remains to be seen in future research how
robust our result is, because our information on road traffic
accidents was limited to published crude estimates on risk
exposures and relative risks. We also applied relative risks of
suicide to falls, homicide, and other injuries because of the lack of
evidence. In order to make a convincing argument on mortality
from alcohol-related injuries in Japan, we need to wait for more
detailed data and evidence to be accumulated and be made
accessible.
One of distinctive characteristics of adult mortality in Japan is a
large number of cancer deaths attributable to infectious agents,
which is possibly common in East-Asian countries [26,60].
Mortality from stomach cancer related to H. pylori is substantial
in Japan, because of the relatively high prevalence of this infection
[26]. However, a decline in the prevalence of H. pylori infection
was observed among people born after 1955 [38], who
experienced improved hygienic conditions under rapid economic
growth in early childhood. This favorable trend predicts a future
reduction in the burden of gastric cancer attributable to H. pylori in
Japan. Moreover, chronic infection from hepatitis C virus is
responsible for the majority of cases of hepatocellular carcinoma in
Japan, while hepatitis B virus plays the major role in most Asian
countries [61]. A considerable part of mortality attributable to
hepatitis C virus infection occurred among people born in the
early 1930s. The risk of becoming infected with hepatitis viruses
was high in this birth cohort, because intravenous use of
methamphetamines was endemic in Japan in their young
adulthood [27,62]. The spread of hepatitis viruses from drug
abusers to the general population in the 1950s and 1960s was most
likely mediated by transfusion of unscreened or commercial blood
and blood products and by medical practices such as needle
sharing for immunizations [62]. The decreasing prevalence of
infections with hepatitis C virus after the birth cohort of around
1935 indicates that the mortality burden of this infectious agent
will diminish in the foreseeable future.
Will the estimated improvements in population health outcomes
be worth all the efforts required of the government, citizens, and
health care workers involved in the modification of risk factors?
The overall increases in life expectancy associated with improved
risk factor exposures may appear small in comparison with
observed improvements in Japanese longevity over previous
decades. This is, however, consistent with a past study’s finding
showing that even complete elimination of deaths from major
causes would not affect life expectancy as much as anticipated in
the US, and an additional drop in mortality would have only a
marginal effect in countries where the rapid increases of life
expectancy have already ended [63]. A study in Sweden also
suggested that the main improvements in increasing a life span
come from changes in death rates among the oldest groups [64].
In order for the aging population to continue the constant progress
in longevity, it is essential to decrease mortality in older ages
through the control of risk factors for non-communicable diseases
and injuries. Working on risk factors in younger generations is
especially important from this standpoint to ensure further
improvement in Japanese life expectancy in the long run.
Our study was based on global efforts of various agencies to pool
evidence on causality and consistency of relative risks. We also
used Japanese population evidence from large-scale cohort studies
if they confirmed established causality, although effects of excess
risks should not vary across populations [20]. We believe,
however, that our effort was justified because the pooled estimates
of these large-scale studies reflected the magnitude of the
proportional effects of risk factors in the specific context of the
Japanese population.
Our analysis had several limitations that should be noted. First,
we focused on impacts of risk factors on mortality relative to
changes in life expectancy and did not account for morbidity and
disability. It is important in future studies to integrate these
nonfatal health outcomes and examine disability-adjusted life
years under the framework of comparative risk assessment in
Japan. This is particularly true because the prognosis of non-
communicable diseases has been improving with enhanced access
to care, advances in medical technologies, and the standardization
of treatment. Second, we could not incorporate standard
metabolic equivalents in the categorization of exposures to
physical inactivity because of the lack of detailed data from the
2007 survey, but instead we adopted a broader classification based
on only the intensity and duration of physical activity that was
used in the Global Burden of Disease Study in 2000. Third, data
on dietary sodium intake until 1995 were recorded at the
household level, which might increase uncertainty concerning
the estimated stroke mortality attributable to high blood pressure
in the early years. Fourth, we employed LDL cholesterol as an
exposure metric for high concentrations of serum cholesterol,
because it is the major atherogenic lipoprotein and a primary
target for prevention of coronary heart disease [65]. It is, however,
also a possibility for future studies to examine effects of low
concentrations of high density lipoproteins, because growing
evidence indicates that it plays an important role in atherogenesis
[65]. Last, some of the Japanese population studies included in this
analysis did not exclude disease end points occurring within a
certain period after baseline in estimating relative risks. A few
studies, however, conducted additional analyses and proved that
changes in their results were minor.
A Comparative Risk Assessment in Japan
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additional efforts in a variety of fields are required for decreasing
adult mortality from chronic diseases and injuries. A first step will
be to powerfully promote effective programs for smoking cessation.
Indeed, tobacco smoking is deeply rooted in Japanese society, and
coordinating among interests of ministries and industries is hard.
Health care professionals, including physicians, who are highly
conscious of the harms of tobacco will play the primary role in
treatment of smoking and creating an environment for implemen-
tation of stringent tobacco control policies. Moreover, it is urgent
to establish a monitoring system for management of high blood
pressure at the national level. Further investigation through
national health surveys will help understand factors that contribute
to the inadequate control of blood pressure in the Japanese
population. Measuring the quality of the care that is actually
delivered by interventions will be of paramount importance in the
assessment of current policies and programs for the treatment of
multiple cardiovascular risks including hypertension. These
concerted actions in research, public health, clinical practice,
and policymaking will be the key for maintaining good population
health in the aging society.
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Background. Worldwide, a small number of modifiable risk
factors are responsible for many premature or preventable
deaths. For example, having high blood pressure
(hypertension) increases a person’s risk of developing life-
threatening heart problems and stroke (cardiovascular
disease). Similarly, having a high blood sugar level
increases the risk of developing diabetes, a chronic (long-
term) disease that can lead to cardiovascular problems and
kidney failure, and half of all long-term tobacco smokers in
Western populations will die prematurely from diseases
related to smoking, such as lung cancer. Importantly, the five
major risk factors for death globally—high blood pressure,
tobacco use, high blood sugar, physical inactivity, and
overweight and obesity—are all modifiable. That is, lifestyle
changes and dietary changes such as exercising more,
reducing salt intake, and increasing fruit and vegetable
intake can reduce an individual’s exposure to these risk
factors and one’s chances of premature death. Moreover,
public health programs designed to reduce a population’s
exposure to modifiable risk factors should reduce
preventable deaths in that population.
Why Was This Study Done? In 2000, the Japanese
government initiated Health Japan 21, a ten-year national
health promotion campaign designed to prevent premature
death from non-communicable (noninfectious) diseases and
injuries. This campaign set 59 goals to monitor and improve
risk factor management in the Japanese population, which
has one of the longest life expectancies at birth in the world
(the life expectancy of a person born in Japan in 2009 was
83.1 years). Because the campaign’s final evaluation revealed
deterioration or no improvement on some of these goals,
the Japanese government recently released new guidelines
that stress the importance of simultaneously controlling
multiple risk factors for chronic diseases. However, although
several studies have quantified the impacts on life
expectancy and cause-specific death of individual
modifiable risk factors in Japan, the effects of multiple risk
factors have not been assessed. In this study, the researchers
use a ‘‘comparative risk assessment’’ framework to estimate
the effects of 16 risk factors on cause-specific deaths and life
expectancy in Japan. Comparative risk assessment estimates
the number of deaths that would be prevented if current
distributions of risk factor exposures were changed to
hypothetical optimal distributions.
What Did the Researchers Do and Find? The researchers
obtained data on exposure to the selected risk factors from
the 2007 Japanese National Health and Nutrition Survey and
from epidemiological studies, and information on the
number of deaths in 2007 from different diseases from
official records. They used published studies to estimate how
much each factor increases the risk of death from each
disease and then used a mathematical formula to estimate
the effects of the risk factors on the number of deaths in
Japan and on life expectancy at age 40. In 2007, tobacco
smoking and high blood pressure accounted for 129,000 and
104,000 deaths, respectively, in Japan. Physical inactivity
accounted for 52,000 deaths, high blood glucose and high
dietary salt intake accounted for 34,000 deaths each, and
alcohol use for 31,000 deaths. Life expectancy at age 40 in
2007 would have been extended by 1.4 years for both
sexes, the researchers estimate, if exposure to multiple
cardiovascular risk factors had been reduced to calculated
optimal distributions, or by 0.7 years if these risk factors had
been reduced to the distributions defined by national
guidelines and goals.
What Do These Findings Mean? These findings identify
tobacco smoking and high blood pressure as the major risk
factors for death from non-communicable diseases among
adults in Japan, a result consistent with previous findings
from the US. They also indicate that simultaneous control of
multiple risk factors has great potential for producing health
gains among the Japanese population. Although the
researchers focused on estimating the effect of these risk
factors on mortality and did not include illness and disability
in this study, these findings nevertheless identify two areas
of public health policy that need to be strengthened to
improve health, reduce death rates, and increase life
expectancy among the Japanese population. First, they
highlight the need to reduce tobacco smoking, particularly
among men. Second and most importantly, these findings
emphasize the need to improve ongoing programs designed
to help people manage multiple cardiovascular risk factors,
including high blood pressure.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001160.
N The US Centers for Disease Control and Prevention
provides information on all aspects of healthy living
N The World Health Report 2002—Reducing Risks, Promoting
Healthy Life provides a global analysis of how healthy life
expectancy could be increased
N The American Heart Association and the American Cancer
Society provide information on many important risk factors
for noncommunicable diseases and include some personal
stories about keeping healthy
N Details about Health Japan 21 are provided by the
Japanese Ministry of Health, Labour and Welfare. Further
details about this campaign are available from the World
Health Organization
N MedlinePlus provides links to further resources on healthy
living and on healthy aging (in English and Spanish)
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